Skip to main content
. 2017 Nov 2;162(1):36–42. doi: 10.1093/toxsci/kfx233

Figure 1.

Figure 1.

Metabolic syndrome with its associated risk factors and diseases at the intersection with drug toxicity (TG, triglycerides; HDL-c, high-density lipoprotein cholesterol; PCOS, polycystic ovary syndrome; NASH, nonalcoholic steatohepatitis). Metabolic Syndrome: Toxicology’s Next Patient, Communiqué Winter 2017, Released on February 16, 2017, ©2017 Society of Toxicology. All rights reserved.

OSZAR »